Moreover, 14% of the patients included in this study harbored deleterious mutations in Fanconi anemia genes (FANCA, FANCD2, FANCF, FANCG FANCI and FANCL) and in WRN, which have been reported to interact with BRCA1 [58–60]. The gene discussed is FANCL; the disease is Fanconi anemia.